Vladimir Tolstikov

Vladimir Tolstikov has been working in the field of science since 2000. Vladimir began their career as a Senior Scientist at the Max Plank Institute in 2000. In 2004, they moved to the Virginia Bioinformatics Institute as a Postdoctoral Scientist. From 2005 to 2012, they were the Metabolomics Core Facility Director at the University of California, where they successfully oversaw the start-up and development of the facility, as well as developed and validated GC-MS and LC-MS services provided nationwide and internationally. In 2012, they moved to Eli Lilly and Company as a Scientist. In 2014, they became the Director of Metabolomics at BERG Health, where they played a key role in the start-up and development of the Metabolomics Unit. Vladimir was responsible for supervision, management, daily operations, R&D, and bioinformatics. In 2022, they moved to Diagnose Early as a Senior Scientist.

Vladimir Tolstikov received their Doctor of Philosophy - PhD in Organic Chemistry from VNIIKHSZR in 1984. Vladimir also obtained a PhD in Organic Chemistry from VNIIKHSZR, Moscow, RF in 1983. Their educational background began with an MS in Chemistry from Lomonosov Moscow State Academy of Fine Chemical Technology (MITHT) in 1977.